UCB-C87085

Study Sponsor : UCB

Study Title

Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease

Medicine or Vaccine (generic name)

Certolizumab Pegol

Sponsor Identification Number

C87085

Trial Registry Identification Number(#'s)

NCT00552058

Medical Condition

Crohn's Disease

Phase

Phase 3

Link to study details on the UCB Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Analysis and Reporting Dataset is AD not ADaM

Datasets are available in English only

Date Added to this Site

February 2016